EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 19 dubna 2024. Database contains 4821 unique substances/entries.
Filter the list
|
A complex combination of polycyclic aromatic hydrocarbons obtained from coal tar having an approximate distillation range of 300°C to 400°C (572°F to 752°F). Composed primarily of phenanthrene, anthracene and carbazole
|
292-602-7
|
90640-80-5
|
Carc. 1B |
yes |
|
|
201-549-0
|
84-65-1
|
Carc. 1B |
|||
|
231-601-8
|
7647-18-9
|
Skin Corr. 1B |
|||
|
233-047-2
|
10025-91-9
|
Skin Corr. 1B |
|||
|
232-009-2
|
7783-56-4
|
Acute Tox. 3 |
|||
|
215-175-0
|
1309-64-4
|
Carc. 2 |
|||
|
201-706-3
|
86-88-4
|
Acute Tox. 2; Carc. 2 |
|||
|
268-618-5
|
68131-49-7
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|||
|
292-697-5
|
90989-41-6
|
Carc. 1B; Muta. 1B |
|||
|
A complex combination of hydrocarbons obtained by the fractionation pyrolysis at 816°C (1500°F) of naphtha and raffinate. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C6 through C8, including benzene.
|
270-658-3
|
68475-70-7
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
A complex combination of hydrocarbons obtained by separation from the platformate-containing fraction. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C7 through C12 (primarily C8) and can contain nonaromatic hydrocarbons, both boiling in the range of approximately 130°C to 200°C (266°F to 392°F).
|
297-401-8
|
93571-75-6
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
292-698-0
|
90989-42-7
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|||
|
295-279-0
|
91995-18-5
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|||
|
292-695-4
|
90989-39-2
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
|||
|
A complex combination of hydrocarbons obtained from the evaporation of solvent under vacuum from polymerized hydrocarbon resin. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C9 and boiling in the range of approximately 120°C to 215°C (248°F to 419°F).
|
295-281-1
|
91995-20-9
|
Carc. 1B; Muta. 1B |
||
|
292-694-9
|
90989-38-1
|
Carc. 1B; Muta. 1B |
|||
|
295-551-9
|
92062-36-7
|
Carc. 1B; Muta. 1B |
|||
|
A complex combination of hydrocarbons produced by the distillation of the products from a steam cracking process treated with hydrogen in the presence of a catalyst. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly greater than C10 and boiling in the range of approximately 150°C to 320°C (302°F to 608°F).
|
292-621-0
|
90640-98-5
|
Asp. Tox. 1 |
||
|
231-148-6
|
7440-38-2
|
Acute Tox. 3 |
|||
|
231-901-9
|
7778-39-4
|
Carc. 1A; Acute Tox. 3 |
yes |
||
|
232-066-3
|
7784-42-1
|
Flam. Gas 1; Press. Gas; Acute Tox. 2; STOT RE 2 |
|||
|
217-617-8
|
1912-24-9
|
STOT RE 2; Skin Sens. 1 |
|||
|
200-104-8
|
51-55-8
|
Acute Tox. 2 |
|||
|
265-610-3
|
65195-55-3
|
Repr. 2; Acute Tox. 2; Acute Tox. 1; STOT RE 1 |
|||
|
262-102-3
|
60207-31-0
|
Acute Tox. 4 |
|||
|
252-626-0
|
35575-96-3
|
Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT SE 1; Skin Sens. 1 |
|||
|
220-147-6
|
2642-71-9
|
Acute Tox. 2; Acute Tox. 3 |
|||
|
201-676-1
|
86-50-0
|
Acute Tox. 2; Acute Tox. 3; Skin Sens. 1 |
|||
|
203-102-5
|
103-33-3
|
Carc. 1B; Muta. 2; Acute Tox. 4; STOT RE 2 |
|||
|
255-209-1
|
41083-11-8
|
Acute Tox. 2; Acute Tox. 3; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 |
|||
|
227-419-3
|
5834-96-8
|
Acute Tox. 4 |
|||
|
207-802-1
|
495-48-7
|
Acute Tox. 4 |
|||
|
202-930-4
|
101-27-9
|
Acute Tox. 4; Skin Sens. 1 |
|||
|
208-167-3
|
513-77-9
|
Acute Tox. 4 |
|||
|
236-760-7
|
13477-00-4
|
Ox. Sol. 1; Acute Tox. 4 |
|||
|
233-788-1
|
10361-37-2
|
Acute Tox. 3; Acute Tox. 4 |
|||
|
236-710-4
|
13465-95-7
|
Ox. Sol. 1; Acute Tox. 4 |
|||
|
215-128-4
|
1304-29-6
|
Ox. Sol. 2; Acute Tox. 4 |
|||
|
256-814-3
|
50864-67-0
|
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
244-214-4
|
21109-95-5
|
Acute Tox. 4 |
|||
|
201-622-7
|
85-68-7
|
Repr. 1B |
yes |
||
|
223-297-0
|
3813-05-6
|
Eye Irrit. 2; Skin Irrit. 2 |
|||
|
245-216-8
|
22781-23-3
|
Acute Tox. 3; Acute Tox. 2 |
|||
|
241-775-7
|
17804-35-2
|
Muta. 1B; Repr. 1B; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
|||
|
207-807-9
|
495-73-8
|
Acute Tox. 3; Acute Tox. 4 |
|||
|
212-010-4
|
741-58-2
|
Acute Tox. 4 |
|||
|
246-585-8
|
25057-89-0
|
Acute Tox. 4; Eye Irrit. 2; Skin Sens. 1 |
|||
|
200-280-6
|
56-55-3
|
Carc. 1B |
yes |
||
|
205-911-9
|
205-99-2
|
Carc. 1B |
|||
|
202-860-4
|
100-52-7
|
Acute Tox. 4 |
|||